Sophiris Bio Accounts Payable

Sophiris Bio (SPHS) currently reports a accounts payable of $430K as of September 2019. That compares with $400K in the prior-year period — up 7.8% year over year. Use the charts on this page to explore Sophiris Bio's accounts payable history and peer comparisons.

Sophiris Bio's accounts payable increased from $400K to $430K — a 7.8% year-over-year increase (period ending September 2019). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sophiris Bio reported $430K in accounts payable as of September 2019. That compares with $400K in the prior-year period — up 7.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $430K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sophiris Bio, and consider following SPHS for alerts when major investors trade the stock.

Sophiris Bio is classified in the Healthcare sector. On accounts payable, it currently shows $430K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SPHS with unrelated industries.